Cargando…
Sivelestat Attenuates Myocardial Reperfusion Injury during Brief Low Flow Postischemic Infusion
The neutrophil elastase inhibitor sivelestat (ONO-5046) possesses unknown mechanisms of cardioprotection when infused following global ischemia, even in the absence of neutrophils. Since myocardial ischemia-reperfusion injury is strongly associated with endothelial dysfunction and reactive oxygen sp...
Autores principales: | Aune, Sverre E., Yeh, Steve T., Kuppusamy, Periannan, Kuppusamy, M. Lakshmi, Khan, Mahmood, Angelos, Mark G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674745/ https://www.ncbi.nlm.nih.gov/pubmed/23766850 http://dx.doi.org/10.1155/2013/279847 |
Ejemplares similares
-
Comparison of Human Induced Pluripotent Stem-Cell Derived Cardiomyocytes with Human Mesenchymal Stem Cells following Acute Myocardial Infarction
por: Citro, Lucas, et al.
Publicado: (2014) -
Supplemental Oxygen Protects Heart Against Acute Myocardial Infarction
por: Prabhat, Anjali M., et al.
Publicado: (2018) -
p53's choice of myocardial death or survival: Oxygen protects infarct myocardium by recruiting p53 on NOS3 promoter through regulation of p53-Lys(118) acetylation
por: Gogna, Rajan, et al.
Publicado: (2013) -
Neutrophil Elastase Inhibitor Sivelestat Attenuates Myocardial Injury after Cardioplegic Arrest in Rat Hearts
por: Fujii, Masahiro, et al.
Publicado: (2019) -
Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
por: Mast, Jesse M., et al.
Publicado: (2018)